Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity. 2018

Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
Department of Pharmaceutical Organic Chemistry, College of Pharmacy, Al-Azhar University, Cairo, 11884, Egypt.

A new series of phenylthiazoles with t-butyl lipophilic component was synthesized and their antibacterial activity against a panel of multidrug-resistant bacterial pathogens was evaluated. Five compounds demonstrated promising antibacterial activity against methicillin-resistant staphylococcal strains and several vancomycin-resistant staphylococcal and enterococcal species. Additionally, three derivatives 19, 23 and 26 exhibited rapid bactericidal activity, and remarkable ability to disrupt mature biofilm produced by MRSA USA300. More importantly, a resistant mutant to 19 couldn't be isolated after subjecting MRSA to sub-lethal doses for 14 days. Lastly, this new series of phenylthiazoles possesses an advantageous attribute over the first-generation compounds in their stability to hepatic metabolism, with a biological half-life of more than 9 h.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D055624 Methicillin-Resistant Staphylococcus aureus A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS. MRSA,Methicillin Resistant Staphylococcus aureus
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm

Related Publications

Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
June 2013, ACS medicinal chemistry letters,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
January 2024, RSC advances,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
October 1982, Journal of medicinal chemistry,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
November 2019, European journal of medicinal chemistry,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
January 1980, International journal of peptide and protein research,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
August 1985, International journal of peptide and protein research,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
July 2023, Biomedicines,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
January 2022, Current pharmaceutical design,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
October 2023, Applied biochemistry and biotechnology,
Ahmed Kotb, and Nader S Abutaleb, and Mohamed A Seleem, and Mohamed Hagras, and Haroon Mohammad, and Ashraf Bayoumi, and Adel Ghiaty, and Mohamed N Seleem, and Abdelrahman S Mayhoub
May 2013, Organic letters,
Copied contents to your clipboard!